AP NEWS
ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Worldwide Industry for Immunohematology to 2025 - Key Players Include Abbott, Antisel and BD Among Others - ResearchAndMarkets.com

December 21, 2020 GMT

DUBLIN--(BUSINESS WIRE)--Dec 21, 2020--

The “Immunohematology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025” report has been added to ResearchAndMarkets.com’s offering.

The global immunohematology market grew at a CAGR of around 6% during 2014-2019. Looking forward, the publisher expects the global immunohematology market to continue its moderate growth during the next five years.

ADVERTISEMENT

Immunohematology refers to a branch of medical sciences that studies blood and blood-forming tissues in relation to the immune system. It is used to study the presence of antigens in the blood and their reaction with antibodies that can either cause hemolysis or red blood cell (RBC) agglutination. Various immunohematology tests are conducted to ensure safe blood transfusion and prevent undesired immunity-, transplant-, and pregnancy-related reactions, and to diagnose blood related disorders and diseases such as HIV, Hepatitis, etc. They utilize various chemicals and devices, such as reagents, and automatic and semi-automatic analyzers that are based on the technology of microplates, biochips, gel cards, polymerase chain reaction and erythrocyte-magnetized technology (EMT).

The increasing prevalence of leukemia and other hematological disorders across the globe is one of the key factors driving the growth of the market. Furthermore, improvements in the healthcare infrastructure and the development of blood banks and trauma centers, especially in developing countries, is also providing a boost to the market growth. Increasing awareness among the masses regarding the activities associated with blood collection, processing, testing and storage has further created a positive impact on the demand for immunohematology devices.

Additionally, various technological advancements, such as the development of innovative transfusion systems and fully-automated devices, are acting as other growth-inducing factors. These next-generation immunohematology devices aid in enhancing the efficacy of the diagnosis, minimizing analysis time and risk of human error, and providing emergency assistance to the patients. Other factors, including an increasing number of blood donation camps and awareness programs, along with improvements in the healthcare infrastructure, are projected to drive the market further.

ADVERTISEMENT

Companies Mentioned

  • Abbott
  • Antisel
  • BD (Becton Dickinson and Company)
  • Beckman Coulter Inc. (Danaher Corporation)
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • Grifols S.A.
  • Merck KGaA
  • MTC Invitro Diagnostics AG
  • Ortho-Clinical Diagnostics Inc (The Carlyle Group)
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global immunohematology market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global immunohematology market?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global immunohematology market and who are the key players?
  • What is the degree of competition in the industry?

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

4.1 Overview

4.2 Key Industry Trends

5 Global Immunohematology Market

5.1 Market Overview

5.2 Market Performance

5.3 Impact of COVID-19

5.4 Market Forecast

6 Market Breakup by Product

6.1 Analyzing Systems

6.1.1 Market Trends

6.1.2 Market Forecast

6.2 Reagents and Consumables

6.2.1 Market Trends

6.2.2 Market Forecast

7 Market Breakup by Technology

7.1 Biochips

7.1.1 Market Trends

7.1.2 Market Forecast

7.2 Gel Cards

7.2.1 Market Trends

7.2.2 Market Forecast

7.3 Microplates

7.3.1 Market Trends

7.3.2 Market Forecast

7.4 Polymerase Chain Reaction

7.4.1 Market Trends

7.4.2 Market Forecast

7.5 Erythrocyte-Magnetized Technology (EMT)

7.5.1 Market Trends

7.5.2 Market Forecast

7.6 Others

7.6.1 Market Trends

7.6.2 Market Forecast

8 Market Breakup by Application

8.1 Blood-Related Diseases

8.1.1 Market Trends

8.1.2 Market Forecast

8.2 HIV

8.2.1 Market Trends

8.2.2 Market Forecast

8.3 Hepatitis

8.3.1 Market Trends

8.3.2 Market Forecast

8.4 Blood Transfusion

8.4.1 Market Trends

8.4.2 Market Forecast

8.5 Others

8.5.1 Market Trends

8.5.2 Market Forecast

9 Market Breakup by End-User

9.1 Hospitals

9.1.1 Market Trends

9.1.2 Market Forecast

9.2 Blood Banks

9.2.1 Market Trends

9.2.2 Market Forecast

9.3 Diagnostic Laboratories

9.3.1 Market Trends

9.3.2 Market Forecast

9.4 Others

9.4.1 Market Trends

9.4.2 Market Forecast

10 Market Breakup by Region

10.1 North America

10.2 Asia Pacific

10.3 Europe

10.4 Latin America

10.5 Middle East and Africa

11 SWOT Analysis

12 Value Chain Analysis

13 Porters Five Forces Analysis

14 Competitive Landscape

14.1 Market Structure

14.2 Key Players

14.3 Profiles of Key Players

For more information about this report visit https://www.researchandmarkets.com/r/incmbk

View source version on businesswire.com:https://www.businesswire.com/news/home/20201221005365/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: BIOTECHNOLOGY INFECTIOUS DISEASES HEALTH PHARMACEUTICAL ONCOLOGY

SOURCE: Research and Markets

Copyright Business Wire 2020.

PUB: 12/21/2020 06:32 AM/DISC: 12/21/2020 06:32 AM

http://www.businesswire.com/news/home/20201221005365/en